Total Funding
65
Total FundingSeries B raised
Growth Score in past quarter
pts
Heat Score 65 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
426501
Arrow is a small pharmaceutical company strictly focussed on novel anti-infective discovery.
About the Company
Arrow Therapeutics was founded in 1998 and is already making a significant contribution to anti-infective drug discovery.
Microbial resistance to existing drugs is an ever increasing threat that is leading to serious unmet medical need and incurring a huge financial burden on society. Despite the huge challenges of this situation it also
presents excellent opportunities to combine scientific research and business. As more and more big pharma groups concentrate their efforts on drug development, greater chances are open to smaller companies such as ours to show their excellence in research.



